Recent articles

It’s early October, which means the Nobel Prizes are being awarded in several categories. These prestigious awards recognize outstanding contributions in Peace, Literature, Physics, Chemistry, Physiology or Medicine, and Economic Sciences. They go to the best and brightest people with the best and brightest ideas. This year, the prizes recognize work that is, in several […]

A new study published in Cell and summarized in Nature has shown positive results using stem cell-derived islets to restore insulin production in a patient with type 1 diabetes (T1D). These results add to the mounting evidence that stem cell-derived islets can provide benefits to people with T1D. The study, conducted by investigators in Beijing, […]

On October 1st, the T1D community got a big win: the Centers for Medicare and Medicaid Servies (CMS) introduced a unique ICD-10 code for stage 2 type 1 diabetes (T1D). This addresses a significant gap in clinical care. Prior to this change, clinicians had limited options for coding stage 2 T1D, which resulted in inaccurate […]

Breakthrough T1D celebrates Hispanic Heritage Month by honoring the history, achievements, and contributions of our Hispanic communities.

The research presented at EASD covered Breakthrough T1D’s entire research portfolio, encompassing disease-modifying therapies, cell therapies, and complications.

At the ADA Scientific Sessions, scientists will present the latest T1D research, all with the goal of improving lives for the T1D community.

Press releases

Read the latest press releases and statements from Breakthrough T1D.

Get the Latest T1D Updates

Sign up for our monthly mission progress newsletter, The Pipeline, to stay up to date on everything you need to know about T1D, from research to advocacy, to clinical care – and everything in between.

  • This field is for validation purposes and should be left unchanged.